We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $397M
1-Year Est. Return 178.66%
This Fund
S&P 500
This Quarter Est. Return
+18.32%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$66.3M
AUM Growth
-$18.1M
Cap. Flow
-$25.3M
Cap. Flow %
-38.23%
Top 10 Hldgs %
20.61%
Holding
140
New
44
Increased
14
Reduced
33
Closed
49

Sector Composition

Rank Sector Weight
1 Industrials 21.52%
2 Healthcare 21.22%
3 Technology 19.84%
4 Consumer Discretionary 12.38%
5 Materials 5.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMED
51
DELISTED
Amedisys
AMED
$643K 0.97%
12,745
-1,115
-8% -$56.3K
WBMD
52
DELISTED
WebMD Health Corp.
WBMD
$628K 0.95%
+10,810
New +$676K
DLTH icon
53
Duluth Holdings
DLTH
$155M
$621K 0.94%
25,372
-51,390
-67% -$1.21M
PRAH
54
DELISTED
PRA Health Sciences, Inc.
PRAH
$591K 0.89%
+14,150
New +$652K
WAL icon
55
Western Alliance Bancorporation
WAL
$8.79B
$581K 0.88%
+17,785
New +$625K
ADPT
56
DELISTED
Adeptus Health Inc
ADPT
$557K 0.84%
10,790
+120
+1% +$7.19K
MKSI icon
57
MKS Inc
MKSI
$20.1B
$542K 0.82%
+12,585
New +$488K
SPNC
58
DELISTED
Spectranetics Corp
SPNC
$537K 0.81%
28,680
-22,465
-44% -$396K
CRZO
59
DELISTED
Carrizo Oil & Gas Inc
CRZO
$524K 0.79%
14,610
-11,445
-44% -$409K
NBIX icon
60
Neurocrine Biosciences
NBIX
$16.8B
$520K 0.78%
11,446
-1,520
-12% -$70K
CY
61
DELISTED
Cypress Semiconductor
CY
$515K 0.78%
+48,810
New +$465K
ABMD
62
DELISTED
Abiomed Inc
ABMD
$511K 0.77%
4,675
+1,945
+71% +$194K
PE
63
DELISTED
PARSLEY ENERGY INC
PE
$511K 0.77%
+18,870
New +$468K
ZEN
64
DELISTED
ZENDESK INC
ZEN
$509K 0.77%
+19,290
New +$466K
AEIS icon
65
Advanced Energy
AEIS
$11.6B
$505K 0.76%
+13,305
New +$476K
RDUS
66
DELISTED
Radius Health, Inc.
RDUS
$477K 0.72%
+12,985
New +$459K
ITCI
67
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$476K 0.72%
+12,260
New +$441K
CSII
68
DELISTED
Cardiovascular Systems, Inc.
CSII
$472K 0.71%
+25,685
New +$401K
MANH icon
69
Manhattan Associates
MANH
$11.2B
$459K 0.69%
7,160
+130
+2% +$8.1K
DERM
70
DELISTED
Dermira, Inc.
DERM
$453K 0.68%
+15,480
New +$427K
GKOS icon
71
Glaukos
GKOS
$9.83B
$452K 0.68%
+15,490
New +$359K
GWRE icon
72
Guidewire Software
GWRE
$12.6B
$423K 0.64%
+6,845
New +$394K
ARIA
73
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$421K 0.64%
+57,015
New +$428K
VEEV icon
74
Veeva Systems
VEEV
$33.1B
$404K 0.61%
+11,830
New +$351K
ACAD icon
75
Acadia Pharmaceuticals
ACAD
$4.43B
$401K 0.6%
12,355
-25,215
-67% -$844K

Similar funds

Lisanti Capital Growth's Q2 2016 Portfolio in Review

As of Q2 2016, Lisanti Capital Growth held 140 positions worth $66.3M, down 21% from $84.4M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Lisanti Capital Growth withdrew a net $25.3M in Q2 2016, closing 49 positions and reducing 33 holdings. Its most notable exit was MACOM Technology Solutions, an estimated $1.66M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Lisanti Capital Growth opened a new position in Berry Global Group, Inc. worth $1.25M.

  • Lisanti Capital Growth's largest Q2 2016 buy was Berry Global Group, Inc.: 35,017 shares worth $1.25M.
  • Lisanti Capital Growth added most to Dycom Industries in Q2 2016, an estimated $798K increase.
  • Lisanti Capital Growth's biggest Q2 2016 reduction was Duluth Holdings, cutting an estimated $1.21M.
  • Lisanti Capital Growth fully exited MACOM Technology Solutions in Q2 2016, selling an estimated $1.66M.
  • Lisanti Capital Growth's ten largest holdings make up 21% of its $66.3M portfolio in Q2 2016.
  • Lisanti Capital Growth opened 44 new positions and closed 49 in Q2 2016.
  • Lisanti Capital Growth's portfolio value fell 21% quarter-over-quarter to $66.3M.

Based on Lisanti Capital Growth's 13F filing for Q2 2016, filed 5 Aug 2016.